Histone Deacetylase Inhibitors Modulate Interleukin 6-dependent CD4+T Cell Polarizationin Vitroandin Vivo
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Histone Deacetylase Inhibitors Modulate Interleukin 6-dependent CD4+T Cell Polarizationin Vitroandin Vivo
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 289, Issue 9, Pages 6142-6151
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2014-01-14
DOI
10.1074/jbc.m113.517599
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Contributions of dendritic cells and macrophages to intestinal homeostasis and immune defense
- (2013) Julia Farache et al. IMMUNOLOGY AND CELL BIOLOGY
- Phase I Trial of Vorinostat Combined With Bortezomib for the Treatment of Relapsing and/or Refractory Multiple Myeloma
- (2012) Donna M. Weber et al. Clinical Lymphoma Myeloma & Leukemia
- Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis
- (2011) Jelena Vojinovic et al. ARTHRITIS AND RHEUMATISM
- Blockade of IL-6-signaling inhibits the pathogenesis of CD4+ T cell-mediated lethal graft-versus-host reaction against minor histocompatibility antigen
- (2011) Daisuke Noguchi et al. IMMUNOLOGY LETTERS
- Loss of CD4 + T Cell IL-6R Expression during Inflammation Underlines a Role for IL-6 Trans Signaling in the Local Maintenance of Th17 Cells
- (2010) Gareth W. Jones et al. JOURNAL OF IMMUNOLOGY
- Clinical aspects of inflammatory bowel disease
- (2009) Britta Siegmund et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Inhibition of HDAC9 Increases T Regulatory Cell Function and Prevents Colitis in Mice
- (2009) Edwin F. de Zoeten et al. GASTROENTEROLOGY
- Pleiotropic anti-myeloma activity of ITF2357: inhibition of interleukin-6 receptor signaling and repression of miR-19a and miR-19b
- (2009) K. Todoerti et al. HAEMATOLOGICA
- Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohnʼs disease
- (2009) Bruce E. Sands et al. INFLAMMATORY BOWEL DISEASES
- Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells
- (2008) H. J. P. M. Koenen et al. BLOOD
- RORγ-Expressing Th17 Cells Induce Murine Chronic Intestinal Inflammation via Redundant Effects of IL-17A and IL-17F
- (2008) Moritz Leppkes et al. GASTROENTEROLOGY
- Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice
- (2008) R. Glauben et al. GUT
- Foxp3 Inhibits RORγt-mediatedIL-17AmRNA Transcription through Direct Interaction with RORγt
- (2008) Kenji Ichiyama et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Blocking TH 17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo
- (2008) Daniela Bosisio et al. JOURNAL OF LEUKOCYTE BIOLOGY
- A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses
- (2008) Elisabetta Volpe et al. NATURE IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started